SOCMA President to Lead ChemOutsourcing Keynote Panel on API Supply Base on Wednesday, September 15 at New Jersey Show

LONG BRANCH, N.J., Sept. 13 /PRNewswire/ -- SOCMA President & CEO Lawrence Sloan will lead the keynote panel discussion at the annual ChemOutsourcing conference this coming Wednesday morning. The panel will address the "Shifting Landscape of the API Supply Base" to explore the evolving API supply chain, reports Mark Alexay, the organizer.

Sloan's opening remarks will touch on current global supply chain topics and SOCMA's Bulk Drug Pharmaceutical Task Force. The BPTF was set up to address supply chain concerns and provide information to the FDA and Congress on related issues. The discussion will then be opened up to the speakers.

The panel discussion is organized around the following topics:

  • Legislative & Regulatory Activity
  • Strategies to Better Safeguard API Sourcing
  • Future of API Sourcing

The panel is comprised of the following participants:


M. Bhupathy, Ph.D.

Executive Director, Chemistry R & D Outsourcing

Amgen


Michael Eakins

Principal Consultant

Eakins & Associates


Elut Hsu

VP Business Development

Asymchem Laboratories


Neil Sawant

Associate Director, Development Strategic Sourcing

Novartis


Michael Semo

Consultant, Virtual CMC Team

Eli Lilly


Stuart Silverman

Pharmaceutical Business Development

Pfizer



Press and other contacts may reach ChemOutsourcing organizer Mark Alexay at [email protected], 201 452 4023

ChemOutsourcing is an annual chemical sourcing and ingredients conference & exhibition focused on the pharmaceutical, small molecule biotech, and chemical industries. It takes places in September in New Jersey. The international event is attended primarily by 750-1000 industrial chemists. ChemOutsourcing 2010 will take place from September 13-16 at Ocean Place Resort in Long Branch, NJ. Additional information is available at www.chemoutsourcing.com.

SOURCE ChemOutsourcing

Suggested Articles

PureTech Health has decamped from Cambridge to Boston’s Seaport neighborhood as a step toward growing the company and ramping up its pipeline.

In this week's EuroBiotech Report, Sanofi cuts staff in R&D rejig, AstraZeneca bets on Korea and uniQure weighs buyout bids.

In our EuroBiotech roundup this week, BioNTech and Genmab start cancer trial, Oncopeptides posts cancer data and F-star hires CFO.